AKT1 and prostate carcinoma: Dubrovska et al. found that the PTEN/PI3K/Akt pathways are critical for prostate cancer stem-like cell maintenance and that targeting PI3K signalling may be beneficial in prostate cancer treatment by eliminating prostate cancer stem-like cells [41].